TRPM4 mRNA and protein levels were overexpressed in prostate cancer tissues compared with non-malignant pancreatic ducts [17, 18], and its overexpression conferred increased risk of biochemical recurrence in patients with prostate cancer [18]. This evidence concerns the gene TRPM4 and Familial prostate cancer.